How is the ZyVersa Therapeutics Inc today?

The ZyVersa Therapeutics Inc today is trading in the down by -1.82% at 0.54.

What is ZyVersa Therapeutics Inc Annual Net Profit?

ZyVersa Therapeutics Inc Annual Net Profit rose 90.42% in the last year to $9.41 M. Its sector's average net profit growth for the last fiscal year was -11.04%.

What is ZyVersa Therapeutics Inc Price to Earning Ratio?

ZyVersa Therapeutics Inc Price to Earning Ratio is -0.29, which is negative.

What is ZyVersa Therapeutics Inc Stock Price?

ZyVersa Therapeutics Inc Stock Price fell 87.73% and underperformed its sector by 99.12% in the past year.

What is ZyVersa Therapeutics Inc Quarterly Net profit?

ZyVersa Therapeutics Inc Quarterly Net profit rose 20.16% YoY to $2.26 M. Its sector's average net profit growth YoY for the quarter was -212.78%.

What is ZyVersa Therapeutics Inc Debt to Equity Ratio?

ZyVersa Therapeutics Inc Debt to Equity Ratio is zero as the company is debt-free.

What is ZyVersa Therapeutics Inc Return on Equity(ROE)?

ZyVersa Therapeutics Inc Return on Equity(ROE) for the last financial year was -96.1%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is ZyVersa Therapeutics Inc Mutual Fund Holding?

ZyVersa Therapeutics Inc Mutual Fund Holding increased by 0.34% in the last quarter to 0.66.

What is ZyVersa Therapeutics Inc Institutional Holding?

ZyVersa Therapeutics Inc Institutional Holding decreased by 1.97% in the last quarter to 0.72.

ZyVersa Therapeutics Inc XNAS: ZVSA

ZyVersa Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: ZyVersa Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: ZyVersa Therapeutics Inc
Rating: 0.94983325
Author: Trendlyne DVM scores

about

ZyVersa Therapeutics Inc is a clinical-stage biopharmaceutical company leveraging proprietary technologies to develop drugs for patients with chronic renal or inflammatory diseases with high unmet medical needs. The company has two proprietary global...

0.54 -0.01 (-1.82%)

91.43% Fall from 52W High

21,770 XNAS Volume

XNAS 22 May, 2025 1:26 PM (EDT)

Not Eligible

-

Expensive Valuation

15.8 / 100

Technically Bearish

22.2 / 100

No estimates available

ZyVersa Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

ZyVersa Therapeutics Inc FAQ

How is ZyVersa Therapeutics Inc today?

ZyVersa Therapeutics Inc today is trading in the red, and is down by -1.82% at 0.54.

How has ZyVersa Therapeutics Inc performed historically?

ZyVersa Therapeutics Inc is currently trading down -1.82% on an intraday basis. In the past week the stock rose 8.00%. stock has been down -55.74% in the past quarter and fell -87.73% in the past year. You can view this in the overview section.